Australian state acts on OTC drug dealers
To crackdown on drug dealers, new laws passed by the Victorian state parliament in Australia lowered the threshold for possessing a quantity of pseudoephedrine from 20g to 10g. Pseudoephedrine is extracted from the tablets to make methamphetamine or speed. Possession of 14 packets or more of over-the-counter cold and flu tablets is now a criminal offence.
The new laws are an attempt to stop gangs who buy large quantities of cold and flu medicines from chemists. The new laws also stop children being used for this purpose, as currently it is an offence for an adult to supply drugs to a child, but not for a child to sell drugs to an adult.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze